CLINICAL_TRIALS
trial_result
· 2022-02-10
Clinical Trial Update: Pharmacokinetic-pharmacodynamic Analysis of Sugammadex for Conventional Reversal in Children [Phase 2]
Summary
Phase 2 trial assessing pharmacokinetic-pharmacodynamic analysis of sugammadex for conventional reversal in children has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seoul National University Hospital | Conditions: Anesthesia, General, Neuromuscular Blockade | Phase 2 | Status: COMPLETED